KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Opko Health (OPK) Revenue: 2010-2025

Historic Revenue for Opko Health (OPK) over the last 16 years, with Sep 2025 value amounting to $151.7 million.

  • Opko Health's Revenue rose 529.33% to $151.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $642.1 million, marking a year-over-year increase of 14.27%. This contributed to the annual value of $713.1 million for FY2024, which is 17.41% down from last year.
  • Latest data reveals that Opko Health reported Revenue of $151.7 million as of Q3 2025, which was down 3.28% from $156.8 million recorded in Q2 2025.
  • Opko Health's 5-year Revenue high stood at $545.2 million for Q1 2021, and its period low was $1.0 million during Q3 2021.
  • Over the past 3 years, Opko Health's median Revenue value was $173.7 million (recorded in 2024), while the average stood at $150.0 million.
  • Its Revenue has fluctuated over the past 5 years, first tumbled by 99.77% in 2021, then soared by 17,874.40% in 2022.
  • Quarterly analysis of 5 years shows Opko Health's Revenue stood at $401.3 million in 2021, then plummeted by 53.82% to $185.3 million in 2022, then decreased by 1.85% to $181.9 million in 2023, then rose by 0.95% to $183.6 million in 2024, then surged by 529.33% to $151.7 million in 2025.
  • Its Revenue stands at $151.7 million for Q3 2025, versus $156.8 million for Q2 2025 and $150.0 million for Q1 2025.